CBI's Interactive Response Technologies for Clinical Trials - the Only IVR/IWR Event of Its Kind - Will Be in Philadelphia on November 14-15, 2011

BOSTON, Oct. 25, 2011 /PRNewswire/ -- Eighteen leading industry speakers will present at Interactive Response Technologies for Clinical Trials on November 14-15, 2011 in Philadelphia. Nearly 100 IRT professionals convene for this interactive and educational exploration of the major shift taking place in clinical trials - using IVR/IWR to collect and analyze clinical trial data.

Many bio/pharmaceutical companies look to mitigate delays, minimize costs and increase overall operational efficiencies through their IVR/IWR systems. Moreover, companies are striving to identify preferred vendors. During the session, "Assess the Operational Value of Establishing Preferred IRT Vendors," Sunny Xie, Senior Director, Process Optimization, Clinical Development Operations & Biometrics and Kate Chapman, Associate Director, IRT Services, both of Shire Pharmaceuticals, uncover an effective model for managing this vendor relationship. Five real-world case studies round out the educational opportunities.

Networking is available both days with such industry leaders as Biogen Idec, Merck Sharpe & Dohme, Boehringer Ingelheim, Abbott, Millennium, Takeda, Johnson & Johnson, Novartis, Allergen, and many more.

For more information and details on how to register for this event, visit http://www.cbinet.com/IVR.

Contact:  

Cathy Rossi-Cecere
Phone number: 339-298-2128
Email address: [email protected]

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE CBI